140 related articles for article (PubMed ID: 230111)
1. Poliovirus antibodies in age groups: an assessment of obligatory vaccination in Belgium.
Lamy ME; Cornu C; Desmyter J
Dev Biol Stand; 1979; 43():207-13. PubMed ID: 230111
[TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis vaccines in Belgium: 20 years of experience.
Andre FE
Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
[No Abstract] [Full Text] [Related]
3. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies.
Pírez MC; Olivera I; Diabarboure H; Montano A; Barañano R; Badía F; Bonnet MC
Vaccine; 2009 May; 27(20):2689-94. PubMed ID: 19428880
[TBL] [Abstract][Full Text] [Related]
4. Immunity of the Croatian population to poliomyelitis--a serosurvey.
Borcić B; Kruzić V; Kaić B; Ljubin-Sternak S; Ljubicić M; Dobrovsak-Sourek V
Acta Med Croatica; 1998; 52(4-5):229-33. PubMed ID: 9988903
[TBL] [Abstract][Full Text] [Related]
5. 2001 serological survey in the Czech Republic--poliomyelitis.
Matyásová I; Rainetová P; Cástková J
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
[TBL] [Abstract][Full Text] [Related]
7. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
[TBL] [Abstract][Full Text] [Related]
8. [Status of immunity against poliomyelitis. Polio serosurvey in 1993].
Diedrich S; Schreier E
Dtsch Med Wochenschr; 1995 Feb; 120(8):239-44. PubMed ID: 7867480
[TBL] [Abstract][Full Text] [Related]
9. [Unusual defective antibody reaction after polio vaccination (author's transl)].
Henigst W; Klose P; Paulig R
MMW Munch Med Wochenschr; 1975 Jan; 117(3):83-6. PubMed ID: 803613
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
11. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
Goldblum N; Kra-Oz Z; Swartz T
Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
[TBL] [Abstract][Full Text] [Related]
12. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
[TBL] [Abstract][Full Text] [Related]
13. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
[TBL] [Abstract][Full Text] [Related]
15. Polio antibody outfit of newborns and infants born after 20 years of mass vaccination with live poliovaccine.
Koza J; Matyásová I; Danes L; Skovránek V; Havelková M
J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):25-32. PubMed ID: 6325534
[TBL] [Abstract][Full Text] [Related]
16. Poliovirus antibody status after vaccination with trivalent oral vaccine.
Clara R; Deprettere A; van der Berghe D; Pattyn S
Acta Paediatr Belg; 1976; 29(4):245-51. PubMed ID: 192040
[No Abstract] [Full Text] [Related]
17. A seroprevalence study of poliovirus antibody in the population of northern Greece.
Frantzidou F; Diza E; Halkia D; Antoniadis A
Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
[TBL] [Abstract][Full Text] [Related]
18. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
Zabicka J
Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
[No Abstract] [Full Text] [Related]
19. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
20. [Implementing secondary poliomyelitis vaccination].
Pietsch R; Riegel H
Gesundheitswesen; 1992 Dec; 54(12):714-5. PubMed ID: 1366256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
